Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (71-80 of 298) with videos related to

Pageof 30
Sort By:
Frontiers in Neuroscience|November 16, 2020
Corrigendum: Low-Dimensional Motor Cortex Dynamics Preserve Kinematics Information During Unconstrained Locomotion in Nonhuman PrimatesDavid Xing, Mehdi Aghagolzadeh, Wilson Truccolo, et al.
Neurobiology of Aging|November 20, 2012
Effects of memantine and galantamine on cognitive performance in aged rhesus macaquesJay S Schneider, Elsa Y Pioli, Yang Jianzhong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 29, 2014
Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and DyskinesiaMichel Engeln, Philippe De Deurwaerdère, Qin Li, et al.
Synapse (New York, N.Y.)|January 23, 2016
Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson diseaseThibaud Thiollier, Caisheng Wu, Hugues Contamin, et al.
Trends in Pharmacological Sciences|May 4, 2004
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trialsWassilios Meissner, Michael P Hill, François Tison, et al.
Lancet (London, England)|June 24, 2014
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectivesAnthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, et al.
Molecular Neurobiology|August 1, 2022
The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced NeurodegenerationMargaux Teil, Evelyne Doudnikoff, Marie-Laure Thiolat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 13, 2004
High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonismAbdelhamid Benazzouz, Chun Hwei Tai, Wassilios Meissner, et al.
Neurological Research|March 15, 2003
The deafferented nonhuman primate is not a reliable model of intractable painElsa Y Pioli, Christian E Gross, Wassilios Meissner, et al.
Pageof 30

Showing results (71-80 of 298) with videos related to

Sort By:
Pageof 30
Frontiers in Neuroscience|November 16, 2020
Corrigendum: Low-Dimensional Motor Cortex Dynamics Preserve Kinematics Information During Unconstrained Locomotion in Nonhuman PrimatesDavid Xing, Mehdi Aghagolzadeh, Wilson Truccolo, et al.
Neurobiology of Aging|November 20, 2012
Effects of memantine and galantamine on cognitive performance in aged rhesus macaquesJay S Schneider, Elsa Y Pioli, Yang Jianzhong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 29, 2014
Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and DyskinesiaMichel Engeln, Philippe De Deurwaerdère, Qin Li, et al.
Synapse (New York, N.Y.)|January 23, 2016
Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson diseaseThibaud Thiollier, Caisheng Wu, Hugues Contamin, et al.
Trends in Pharmacological Sciences|May 4, 2004
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trialsWassilios Meissner, Michael P Hill, François Tison, et al.
Lancet (London, England)|June 24, 2014
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectivesAnthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, et al.
Molecular Neurobiology|August 1, 2022
The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced NeurodegenerationMargaux Teil, Evelyne Doudnikoff, Marie-Laure Thiolat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 13, 2004
High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonismAbdelhamid Benazzouz, Chun Hwei Tai, Wassilios Meissner, et al.
Neurological Research|March 15, 2003
The deafferented nonhuman primate is not a reliable model of intractable painElsa Y Pioli, Christian E Gross, Wassilios Meissner, et al.
Pageof 30